綜醫研控股
2385
Nyle
5618
Renascience
4889
Cluster Technology
4240
SecondXight Analytica
5028
(FY)2024/09/30 | (Q2)2024/03/31 | (Q1)2023/12/31 | (FY)2023/09/30 | (Q4)2023/09/30 | (Q3)2023/06/30 | (Q2)2023/03/31 | (Q1)2022/12/31 | (FY)2022/09/30 | (Q4)2022/09/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 29.54%171.14億 | 27.35%40.44億 | 36.95%40.78億 | 24.93%132.11億 | 25.88%35.2億 | 31.97%35.38億 | 20.73%31.76億 | 20.68%29.78億 | 36.10%105.75億 | 27.47%27.96億 |
主營業務成本 | 31.10%92.67億 | 32.42%21.99億 | 41.61%22.38億 | 22.68%70.68億 | 27.53%19.09億 | 31.97%19.18億 | 15.29%16.61億 | 15.29%15.81億 | 34.46%57.62億 | 21.59%14.97億 |
毛利 | 27.75%78.47億 | 21.79%18.45億 | 31.69%18.4億 | 27.63%61.42億 | 23.98%16.11億 | 31.96%16.2億 | 27.32%15.15億 | 27.42%13.97億 | 38.12%48.13億 | 34.98%12.99億 |
營業費用 | 30.41%65.06億 | 24.00%14.96億 | 27.47%14.93億 | 28.58%49.89億 | 2.32%12.78億 | 37.52%13.33億 | 38.84%12.06億 | 47.78%11.72億 | 33.37%38.8億 | 51.42%12.49億 |
營業利潤 | 16.22%13.41億 | 13.17%3.49億 | 53.60%3.46億 | 23.66%11.54億 | 564.00%3.33億 | 11.11%2.87億 | -3.86%3.09億 | -25.77%2.25億 | 62.18%9.33億 | -63.58%5,011萬 |
營業外利息收入與支出淨額 | -151.89%-1,007.8萬 | -359.89%-400.1萬 | -666.67%-154.1萬 | -12.69%-87萬 | -5.24%-20.1萬 | |||||
營業外利息支出 | 151.89%1,007.8萬 | ---- | ---- | 359.89%400.1萬 | 666.67%154.1萬 | ---- | ---- | ---- | 12.69%87萬 | 5.24%20.1萬 |
投資淨收益 | -202.35%-823.9萬 | 12.88%-837萬 | -70.38%805萬 | -23.79%511.8萬 | 1,240.7萬 | 13.2萬 | -960.7萬 | 2,718.1萬 | 671.6萬 | |
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | 10.65%-2,982.7萬 | -581.70%-3,338.3萬 | 55.28%-219萬 | -3,109.1萬 | 52.83%-489.7萬 | -42.98%-489.7萬 | ||||
聯營企業及其他參股權益產生的收益 | -122.33%-1,679.7萬 | 0 | 0 | 89.65%-755.5萬 | 0 | 0 | 99.25%-45萬 | 9.38%-710.5萬 | -7,296.8萬 | 258.4萬 |
特殊收入(費用) | 1,143.8萬 | 0 | 1,143.8萬 | 0 | 0 | 0 | -1,673.6萬 | |||
減:其他特殊費用 | ---1,143.8萬 | --0 | ---1,143.8萬 | ---- | ---- | ---- | ---- | ---- | --1,673.6萬 | ---- |
其他營業外收入(費用) | 22.09%1.1億 | 28.14%6,060萬 | 66.90%1,854.3萬 | 38.09%9,050.1萬 | 24.84%1,822.7萬 | 93.95%1,387.1萬 | 96.62%4,729.3萬 | -43.69%1,111萬 | -12.31%6,553.6萬 | -12.19%1,460萬 |
稅前利潤 | 15.78%13.98億 | 13.91%4.05億 | 67.35%3.68億 | 29.79%12.07億 | 575.29%3.52億 | 0.83%2.8億 | 24.65%3.55億 | -30.34%2.2億 | 45.60%9.3億 | -65.35%5,217.6萬 |
所得稅 | 253.20%4.46億 | 2.78%1.29億 | 115.22%1.51億 | -0.63%1.26億 | 4.55%-1.43億 | -0.68%7,420.5萬 | 22.77%1.25億 | -30.18%7,016.3萬 | 677.93%1.27億 | -78.01%-1.5億 |
除稅後利潤 | -11.99%9.51億 | 19.96%2.76億 | 44.90%2.17億 | 34.61%10.81億 | 145.18%4.95億 | 1.39%2.05億 | 25.69%2.3億 | -30.42%1.5億 | 28.99%8.03億 | -13.94%2.02億 |
持續經營利潤 | -11.99%9.51億 | 19.96%2.76億 | 44.90%2.17億 | 34.61%10.81億 | 145.18%4.95億 | 1.39%2.05億 | 25.69%2.3億 | -30.42%1.5億 | 28.99%8.03億 | -13.94%2.02億 |
歸屬于少數股東的淨利潤 | 355.28%4,040.9萬 | 1,232.9萬 | 283.9萬 | -1,582.9萬 | -404.4萬 | -1,178.5萬 | 0 | 0 | 0 | 0 |
歸屬於母公司的淨利潤 | -16.95%9.11億 | 14.61%2.64億 | 43.00%2.14億 | 36.58%10.97億 | 147.18%4.99億 | 7.21%2.17億 | 25.69%2.3億 | -30.42%1.5億 | 28.99%8.03億 | -13.94%2.02億 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | -16.95%9.11億 | 14.61%2.64億 | 43.00%2.14億 | 36.58%10.97億 | 147.18%4.99億 | 7.21%2.17億 | 25.69%2.3億 | -30.42%1.5億 | 28.99%8.03億 | -13.94%2.02億 |
總派息金額 | ||||||||||
基本每股收益 | -18.15%58.3 | 13.11%17 | 40.76%13.78 | 35.42%71.23 | 144.52%32.35 | 5.95%14.06 | 25.15%15.03 | -30.52%9.79 | 28.80%52.6 | -14.09%13.23 |
稀釋每股收益 | -17.38%57.87 | 14.39%16.85 | 42.59%13.66 | 35.37%70.04 | 145.53%31.87 | 6.04%13.86 | 24.51%14.73 | -30.88%9.58 | 29.09%51.74 | -14.15%12.98 |
每股派息 | 18 | |||||||||
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |